Suppr超能文献

美国超声心动图学会关于超声造影剂在超声心动图临床应用的共识声明。

American Society of Echocardiography Consensus Statement on the Clinical Applications of Ultrasonic Contrast Agents in Echocardiography.

作者信息

Mulvagh Sharon L, Rakowski Harry, Vannan Mani A, Abdelmoneim Sahar S, Becher Harald, Bierig S Michelle, Burns Peter N, Castello Ramon, Coon Patrick D, Hagen Mary E, Jollis James G, Kimball Thomas R, Kitzman Dalane W, Kronzon Itzhak, Labovitz Arthur J, Lang Roberto M, Mathew Joseph, Moir W Stuart, Nagueh Sherif F, Pearlman Alan S, Perez Julio E, Porter Thomas R, Rosenbloom Judy, Strachan G Monet, Thanigaraj Srihari, Wei Kevin, Woo Anna, Yu Eric H C, Zoghbi William A

机构信息

Mayo Clinic, Rochester, MN, USA.

出版信息

J Am Soc Echocardiogr. 2008 Nov;21(11):1179-201; quiz 1281. doi: 10.1016/j.echo.2008.09.009.

Abstract

UNLABELLED

ACCREDITATION STATEMENT: The American Society of Echocardiography (ASE) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The ASE designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit.trade mark Physicians should only claim credit commensurate with the extent of their participation in the activity. The American Registry of Diagnostic Medical Sonographers and Cardiovascular Credentialing International recognize the ASE's certificates and have agreed to honor the credit hours toward their registry requirements for sonographers. The ASE is committed to resolving all conflict-of-interest issues, and its mandate is to retain only those speakers with financial interests that can be reconciled with the goals and educational integrity of the educational program. Disclosure of faculty and commercial support sponsor relationships, if any, have been indicated.

TARGET AUDIENCE

This activity is designed for all cardiovascular physicians, cardiac sonographers, and nurses with a primary interest and knowledge base in the field of echocardiography; in addition, residents, researchers, clinicians, sonographers, and other medical professionals having a specific interest in contrast echocardiography may be included.

OBJECTIVES

Upon completing this activity, participants will be able to: 1. Demonstrate an increased knowledge of the applications for contrast echocardiography and their impact on cardiac diagnosis. 2. Differentiate the available ultrasound contrast agents and ultrasound equipment imaging features to optimize their use. 3. Recognize the indications, benefits, and safety of ultrasound contrast agents, acknowledging the recent labeling changes by the US Food and Drug Administration (FDA) regarding contrast agent use and safety information. 4. Identify specific patient populations that represent potential candidates for the use of contrast agents, to enable cost-effective clinical diagnosis. 5. Incorporate effective teamwork strategies for the implementation of contrast agents in the echocardiography laboratory and establish guidelines for contrast use. 6. Use contrast enhancement for endocardial border delineation and left ventricular opacification in rest and stress echocardiography and unique patient care environments in which echocardiographic image acquisition is frequently challenging, including intensive care units (ICUs) and emergency departments. 7. Effectively use contrast echocardiography for the diagnosis of intracardiac and extracardiac abnormalities, including the identification of complications of acute myocardial infarction. 8. Assess the common pitfalls in contrast imaging and use stepwise, guideline-based contrast equipment setup and contrast agent administration techniques to optimize image acquisition.

摘要

未标注

认证声明:美国超声心动图学会(ASE)经继续医学教育认证委员会认可,可为医生提供继续医学教育。ASE将此教育活动指定为最多1个美国医学协会(AMA)PRA第1类学分。医师应仅根据其参与活动的程度申报学分。美国诊断医学超声医师注册处和心血管认证国际组织认可ASE的证书,并同意认可这些学分小时数,以满足其对超声医师注册要求。ASE致力于解决所有利益冲突问题,其任务是仅保留那些其经济利益与教育项目的目标和教育完整性相协调的演讲者。已注明教员与商业支持赞助商之间的关系(如有)。

目标受众

本活动面向所有对超声心动图领域有主要兴趣和知识基础的心血管内科医生、心脏超声医师和护士;此外,可能包括对超声心动图造影有特定兴趣的住院医师、研究人员、临床医生、超声医师和其他医学专业人员。

目标

完成本活动后,参与者将能够:1. 展示对超声心动图造影应用及其对心脏诊断影响的更多了解。2. 区分可用的超声造影剂和超声设备成像特征,以优化其使用。3. 认识超声造影剂的适应症、益处和安全性,了解美国食品药品监督管理局(FDA)最近关于造影剂使用和安全信息的标签更改。4. 识别代表使用造影剂潜在候选人群的特定患者群体,以实现具有成本效益的临床诊断。5. 纳入在超声心动图实验室实施造影剂的有效团队合作策略,并制定造影剂使用指南。6. 在静息和负荷超声心动图以及超声心动图图像采集经常具有挑战性的独特患者护理环境(包括重症监护病房(ICU)和急诊科)中,使用造影剂增强来勾勒心内膜边界和使左心室显影。7. 有效地使用超声心动图造影诊断心内和心外异常,包括识别急性心肌梗死的并发症。8. 评估造影成像中的常见陷阱,并使用基于指南的逐步造影设备设置和造影剂给药技术来优化图像采集。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验